Related Experiment Videos
Solution structure of human survivin and its binding interface with Smac/Diablo
Chaohong Sun1, David Nettesheim, Zhihong Liu
1Global Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064-6098, USA.
Biochemistry
|January 5, 2005
Summary
Nuclear Magnetic Resonance (NMR) studies reveal the antiapoptotic protein survivin forms a unique dimer structure in solution. These findings clarify survivin
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- The antiapoptotic protein survivin plays a crucial role in cell survival and is a target in cancer therapy.
- Understanding survivin's structure and its interactions is vital for developing targeted therapeutics.
- Previous X-ray crystallography studies presented conflicting models for survivin's homodimerization interface.
Purpose of the Study:
- To elucidate the solution structure of the survivin homodimer using NMR spectroscopy.
- To identify the specific residues involved in survivin dimerization.
- To characterize the structural basis of survivin's interaction with Smac/Diablo.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was employed to study survivin(1-120).
- Solution-state NMR experiments were performed to determine the protein's homodimer interface.
- NMR titration experiments were conducted to map the binding site of Smac/Diablo peptides.
Main Results:
- Survivin(1-120) forms a distinct bow-tie-shaped dimer in solution.
- The homodimer interface involves N-terminal residues and regions connecting the BIR domain to the C-terminal alpha helix.
- NMR data indicate that Smac/Diablo peptides bind to survivin across the third beta-strand, similar to its interaction with XIAP.
- Specific residues near alpha4 and beta3 of survivin are perturbed upon Smac/Diablo binding.
Conclusions:
- The solution structure of the survivin dimer resolves ambiguities from crystal structures.
- NMR provides a detailed understanding of survivin's homodimerization interface.
- The study reveals the structural mechanism underlying survivin's interaction with Smac/Diablo, offering insights for drug development.